188 related articles for article (PubMed ID: 17211251)
21. Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K; Nakahori Y
J Endocrinol; 2009 Jan; 200(1):53-61. PubMed ID: 18931022
[TBL] [Abstract][Full Text] [Related]
22. Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat.
Cooper ME; Allen TJ; Jerums G; Doyle AE
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):655-62. PubMed ID: 3802581
[TBL] [Abstract][Full Text] [Related]
23. Experimental rat models to study the metabolic syndrome.
Aleixandre de Artiñano A; Miguel Castro M
Br J Nutr; 2009 Nov; 102(9):1246-53. PubMed ID: 19631025
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and urinary excretion of sodium in hypertensive patients with non-insulin dependent diabetes mellitus.
Singh SK; Sarkar D; Agrawal JK
J Assoc Physicians India; 1999 Jul; 47(7):709-11. PubMed ID: 10778592
[TBL] [Abstract][Full Text] [Related]
25. Streptozotocin-induced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia.
Ishihara G; Hiramatsu Y; Masuyama H; Kudo T
Metabolism; 2000 Jul; 49(7):853-7. PubMed ID: 10909994
[TBL] [Abstract][Full Text] [Related]
26. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats.
Kumarappan CT; Mandal SC
Ren Fail; 2008; 30(3):307-22. PubMed ID: 18350451
[TBL] [Abstract][Full Text] [Related]
27. Major cardiovascular risk factors in Lyon hypertensive rats. A correlation analysis in a segregating population.
Vincent M; Cartier R; Privat P; Benzoni D; Samani NJ; Sassard J
J Hypertens; 1996 Apr; 14(4):469-74. PubMed ID: 8761896
[TBL] [Abstract][Full Text] [Related]
28. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
30. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
[TBL] [Abstract][Full Text] [Related]
31. [Human essential hypertension and genetic hypertension in rats: the Lyon model].
Sassard J
Bull Acad Natl Med; 2006 Jan; 190(1):111-9; discussion 119-21. PubMed ID: 16878449
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of cicletanine on renal function in diabetic spontaneously hypertensive rats.
Duran MJ; Sennoune S; Arnaud C; Garcia S; Droy-Lefaix MT; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):869-74. PubMed ID: 15672472
[TBL] [Abstract][Full Text] [Related]
33. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
34. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A
Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490
[TBL] [Abstract][Full Text] [Related]
35. Effect of alpha-tocopherol supplementation on blood pressure and lipidic profile in streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats.
Vieira da Costa VA; Vianna LM
Clin Chim Acta; 2005 Jan; 351(1-2):101-4. PubMed ID: 15563877
[TBL] [Abstract][Full Text] [Related]
36. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058
[TBL] [Abstract][Full Text] [Related]
37. New establishment of hypertensive diabetic animal models: neonatally streptozotocin-treated spontaneously hypertensive rats.
Sato T; Nara Y; Note S; Yamori Y
Metabolism; 1987 Aug; 36(8):731-7. PubMed ID: 3600285
[TBL] [Abstract][Full Text] [Related]
38. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
[TBL] [Abstract][Full Text] [Related]
39. Insulin kinetic, glucose tolerance, and lipid metabolism in genetically spontaneous-hypertensive rats.
Baumann R; Moritz V; Gödicke W; Postnow JW; Ziegler M
Acta Biol Med Ger; 1976; 35(6):K 33-9. PubMed ID: 983618
[TBL] [Abstract][Full Text] [Related]
40. Partial transfer of genetic hypertension by lymphoid cells in Lyon rats.
Renaudin C; Bataillard A; Sassard J
J Hypertens; 1995 Dec; 13(12 Pt 2):1589-92. PubMed ID: 8903615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
